
Infectious Disease @OSUWexMed ID Fellowship Program Director. OPAT Medical Director. Opinions are my own, retweet/likes not endorsement. @OhioState_ID
Columbus, OH
Joined October 2017
- Tweets10.8K
- Following1.2K
- Followers1.1K
- Likes14.2K
Come join our fellowship program!
Join us at @OhioState_ID! Comprehensive training in all areas of ID, including HIV, SOT, & BMT, with excellent mentorship. Available tracks in ASP, Epi, HIV, SOT/BMT, & more. Columbus is growing with a big city feel without the hassle. DM or email with questions! #IDTwitter
Mahdee Sobhanie, MD retweeted
Contamination of blood cultures drawn from arterial catheters versus venipuncture or venous catheters in critically ill patients: a systematic review and meta-analysis
✅ Just Accepted
🔗 bit.ly/4kwTXQd
Mahdee Sobhanie, MD retweeted
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015?2024)
✅ Just Accepted
🔗 bit.ly/45dHwEr
Mahdee Sobhanie, MD retweeted
Infant hospitalizations from #RSV were cut nearly in half after the introduction of two RSV preventive measures, as reported in a recent @CDCMMWR. Learn how @UofR, and our Center, played a role in this public health milestone: urmc.rochester.edu/community…
#URochesterResearch
Mahdee Sobhanie, MD retweeted
Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis
✅ Just Accepted
bit.ly/3BM507l
Mahdee Sobhanie, MD retweeted
Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand
✅ Just Accepted
bit.ly/4iPs71I
Mahdee Sobhanie, MD retweeted
Re-infection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial
✅ Just Accepted
🔗 bit.ly/4ftvx79
Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study | Clinical Infectious Diseases | Oxford Academic academic.oup.com/cid/advance…
2
243
Mahdee Sobhanie, MD retweeted
How I Do It: Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes
doi.org/10.1016/j.chest.2024…
Mahdee Sobhanie, MD retweeted
Estimating standard-dose and high-dose Fluzone vaccine efficacies for influenza A based on HAI titers
✅ Just Accepted
🔗 bit.ly/3VHSj4n
Agree!!! We still have one more spot available starting in July 2025. DM me if you are interested!!!
So fortunate to have matched such ⭐️’s! As a graduate of this fellowship program, I have nothing but positive things to say about the overall ID training, faculty, environment, and fellowship leadership (I’m a little biased but the HIV training and mentorship is 🙌🏽 💯!)
256
Mahdee Sobhanie, MD retweeted
Oral doxycycline for the treatment of ocular syphilis may be safe and effective in a selected subset of patients who completed an extended oral antibiotic regimen. ja.ma/4gmGGHP @bradspellberg
Looking forward to working with these two wonderful upcoming ID Fellows! We do have one spot remaining - please do not hesitate to reach out to me if you are interested! We have a great group of faculty and fellows here @OSUWexMed!
We still have one spot available for our ID Fellowship Program starting July 1, 2025. If you are interested please email our program director Dr Sobhanie @IDRenaissanceMD for more information!
Mahdee Sobhanie, MD retweeted
Implementation of a Pharmacist-Driven Vancomycin Area Under the Concentration-Time Curve Monitoring Program Using Bayesian Modeling in Outpatient Parenteral Antimicrobial Therapy
bit.ly/4fNHQfM
Mahdee Sobhanie, MD retweeted
【CMV in solid organ transplant recipients】#CoreCurriculum
👉Incredible lecture on advances in diagnosis and management of CMV by our PD @RazonableMD @MayoClinicINFD!
#IDMedEd #IDFellow @AST_IDCOP @TransplantIDNet
Mahdee Sobhanie, MD retweeted
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of Aeromonas Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases
bit.ly/4hZRI7H
Mahdee Sobhanie, MD retweeted
Oral cephs vs FQ & TMP-SMX for the tx of pyelo in patients dc from the ED 💊
No diff in tx failure between cephs vs FQ and TMP-SMX groups (17.2% of cephs vs 22.5% of FQ & TMP-SMX) 💯
42% Cephalexin & 35.5% Cefdinir 😳
Do you avoid Cefdinir due to the low oral bioavailability?
Mahdee Sobhanie, MD retweeted
Executive Summary: State-of-the-Art Review: Ocular Infections
bit.ly/4i2RvAE
Mahdee Sobhanie, MD retweeted
#IDTwitter @PriyaNori @ASHE_Journal The figure spells it out! Development and validation of an antimicrobial stewardship clinical decision-support tool to improve the management of urinary tract infections versus asymptomatic bacteriuria- bit.ly/4fAaHUx
Mahdee Sobhanie, MD retweeted
Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials
✅ Just Accepted
🔗 bit.ly/48OG62R

























